Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B2 | P37059 | 3/20 | 0.39 |
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | RORA | P35398 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | UQCRB | P14927 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL51945 | 0.88 | ALDH1A1 (0.39) | RORAHSD11B1ALDH1A1 | |
| SCHEMBL5117718 | 0.87 | CYTH2 (0.35) | BRD4HSD11B1 | |
| SCHEMBL5124094 | 0.87 | LMNA (0.42) | HSD17B2RORAHSD11B1ALDH1A1UQCRB | |
| SCHEMBL678361 | 0.86 | ALDH1A1 (0.38) | RORAHSD11B1ALDH1A1 | |
| SCHEMBL1593144 | 0.84 | ALDH1A1 (0.40) | RORAHSD11B1ALDH1A1UQCRB | |
| SCHEMBL2438153 | 0.83 | ALDH1A1 (0.42) | RORAHSD11B1ALDH1A1UQCRB | |
| SCHEMBL5438873 | 0.83 | ALDH1A1 (0.39) | RORAHSD11B1ALDH1A1 | |
| SCHEMBL384049 | 0.83 | HSD11B1 (0.38) | HSD17B2RORAHSD11B1ALDH1A1UQCRB | |
| SCHEMBL3139767 | 0.83 | HSD11B1 (0.38) | HSD17B2RORAHSD11B1ALDH1A1UQCRB | |
| SCHEMBL3137398 | 0.82 | HSD11B1 (0.37) | HSD17B2RORAHSD11B1ALDH1A1UQCRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858287-B2 | Photosensitive resin, and photosensitive composition | HYOGO PREFECTURE (JP) | 2010-12-28 | — | — | US | disclosed |
| US-20090142697-A1 | PHOTOSENSITIVE RESIN, AND PHOTOSENSITIVE COMPOSITION | TOYO GOSEI CO., LTD. (JP) | 2009-06-04 | — | — | US | disclosed |
| US-7396960-B2 | Sulfonium salts | TOYO GOSEI CO., LTD. (JP) | 2008-07-08 | — | — | US | disclosed |
| US-20070219368-A1 | Sulfonium salts | TOYO GOSEI CO., LTD. (JP) | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219368-A1 | Sulfonium salts | C1S, F12, C1R | HSD17B2 1601/4885BRD4 1602/4885RORA 2865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.